BRIEF published on 07/01/2026 at 07:35, 4 months 4 days ago Abivax annonce la suspension temporaire de la cotation de ses actions sur Euronext Paris Euronext Paris Biotechnologie Abivax Offre Publique Suspension Des Échanges
PRESS RELEASE published on 07/01/2026 at 07:30, 4 months 4 days ago Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris pour l'Offre publique et reprise des négociations prévue le 1er juillet 2026 Euronext Paris Abivax Rectocolite Hémorragique Offre Publique Suspension
PRESS RELEASE published on 07/01/2026 at 07:30, 4 months 4 days ago Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris Abivax suspend temporairement le cours de ses actions ordinaires sur Euronext Paris pour l'Offre publique annoncée aux États-Unis, reprise prévue dans l'après-midi Euronext Paris Abivax Reprise Offre Publique Suspension Temporaire
PRESS RELEASE published on 07/01/2026 at 07:30, 4 months 4 days ago Abivax announces temporary trading halt of its ordinary shares on Euronext Paris Abivax announces temporary trading halt of its ordinary shares on Euronext Paris in relation to a public offering for its American Depositary Shares. Trading expected to resume today Euronext Paris Trading Abivax Public Offering Temporary Halt
BRIEF published on 06/30/2026 at 22:53, 4 months 5 days ago Abivax lance une offre publique d'actions de dépôt américaines Biotechnologie Abivax Offre Publique Maladies Inflammatoires Actions De Dépôt Américaines
BRIEF published on 06/30/2026 at 22:53, 4 months 5 days ago Abivax Initiates Public Offering of American Depositary Shares Biotechnology Abivax Public Offering Inflammatory Diseases American Depositary Shares
BRIEF published on 06/30/2026 at 22:51, 4 months 5 days ago Abivax lance une offre au public d'American Depositary Shares Biotechnologie Abivax Obefazimod Nasdaq Ads
BRIEF published on 06/30/2026 at 22:51, 4 months 5 days ago Abivax launches a public offering of American Depositary Shares Biotechnology Abivax Obefazimod Nasdaq Ads
BRIEF published on 06/30/2026 at 22:50, 4 months 5 days ago Abivax launches a public offering of American Depositary Shares Biotechnology Abivax Nasdaq Public Offering American Depositary Shares
BRIEF published on 06/30/2026 at 22:50, 4 months 5 days ago Abivax lance une offre au public d'American Depositary Shares Biotechnologie Abivax Nasdaq Offre Publique American Depositary Shares
Published on 11/06/2026 at 00:53, 1 hour 51 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 1 hour 59 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 2 hours 49 minutes ago Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/05/2026 at 23:20, 3 hours 24 minutes ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/06/2026 at 00:05, 2 hours 39 minutes ago RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 4 hours 38 minutes ago Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 6 hours 5 minutes ago freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 6 hours 7 minutes ago EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 6 hours 58 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 18:21, 8 hours 22 minutes ago Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 8 hours 22 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
